4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000018
CHIEF FINANCIAL OFFICER acquired 29,207 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Andrade Robert · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-31 | Exercise or conversion : show line 1 in the form | +14,724 | 271,380 | D |
| 2026-03-31 | Exercise or conversion : show line 2 in the form | +2,213 | 273,593 | D |
| 2026-03-28 | Exercise or conversion : show line 3 in the form | +12,270 | 285,863 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-31 | Grant or award : show line 4 in the form Stock Options | +120,000 | $5.77 | $692,400 | 921,045 | D |
Loading xslF345X06/form4-04022026_040401.xml…